Portugal vs Tanzania, United Republic of: Share of adolescent girls vaccinated against human papillomavirus
Portugal
96.0%
in 2024
Tanzania, United Republic of
99.0%
in 2024
Portugal rank
3rd
Tanzania, United Republic of rank
1st
Share of adolescent girls vaccinated against human papillomavirus over time
- Portugal
- Tanzania, United Republic of
How they compare
Tanzania, United Republic of currently reports 99.0% against 96.0% in Portugal, a difference of 3.0%.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Portugal ahead.
Portugal ranks 3rd and Tanzania, United Republic of ranks 1st of 74 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Portugal | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.0% | 16.0% | 79.0% | Portugal |
| 2020s | 95.2% | 62.8% | 32.4% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Portugal or Tanzania, United Republic of?
- Tanzania, United Republic of, at 99.0% against 96.0% in Portugal as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Portugal and Tanzania, United Republic of?
- 3.0%, with Tanzania, United Republic of ahead.
- How many years of comparable data are there for Portugal and Tanzania, United Republic of?
- 6 years are reported by both, from 2019 to 2024.
- How do Portugal and Tanzania, United Republic of rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Portugal ranks 3rd and Tanzania, United Republic of ranks 1st of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.